On October 2, 2025, GSK and IQVIA announced a major update to their Vaccine Track data tool, expanding local-level coverage ...

What Happened? Shares of clinical research company IQVIA (NYSE: IQV) jumped 6.3% in the afternoon session after the company, ...

Analysts have set 12-month price targets for IQVIA Hldgs, revealing an average target of $208.88, a high estimate of $235.00, ...

Broyhill Asset Management, an investment advisor, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here.

Shares of IQVIA Holdings Inc. rose 5.10% to $189.94 Tuesday, on what proved to be an all-around great trading session for the ...

Financial Strength IQVIA is in decent financial health, with strong cash flow generation from both its clinical research and technology businesses offset by an above-average debt load. The company ...

A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the ...

IQVIA Holdings Inc. (NYSE:IQV – Get Free Report)’s stock price gapped up prior to trading on Tuesday following a better than expected earnings announcement. The stock had previously closed at $158.96, ...

Iqvia (formerly QuintilesIMS) is the result of the merger of Quintiles, a leading late-stage contract research organization, and IMS Health, a dominant player in life sciences data and analytics. The ...

Apttus and HighPoint, an IQVIA company, Have Partnered To Bring Digital Transformation To Tech Projects Across the Healthcare and Life Sciences Industry SAN MATEO, California, March 9, 2020 ...

Forbes contributors publish independent expert analyses and insights. #1 stock picker for 51 straight months on SumZero. AI is my edge. This article is more than 7 years old. Management teams often ...

DURHAM — A director of Iqvia Holdings Inc. has sold $28.1 million worth of stock in the health information technologies and clinical research company last week, according to a Form 4 filed with the ...